| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$155 |
Financial Results for Quarter Ending 31 March 2025
|
9 May 2025 8:25AM |
$2.990 |
$1.015 |
fallen by
66.05%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Product revenue increased significantly year-over-year, mainly due to higher adoption of RECELL in the U.S.
- Clinical development advanced with ongoing trials in soft tissue reconstruction and vitiligo.
- Gross profit improved, reflecting favorable product mix and operational efficiencies.
- Operating expenses rose as a result of investments in sales, marketing, and research activities.
- Net loss was reported, but the company emphasized a strong cash position to support future operations.
- Key milestones were achieved in regulatory submissions and clinical programs.
- Strategic initiatives focused on expanding addressable markets and driving adoption.
- Positive outlook for continued revenue growth through expanded indications and market reach.
- Management reiterated commitment to innovation and improving patient outcomes.
- Financial guidance and strategic priorities for the upcoming quarters were provided.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$155 |
AVITA Medical Q1 2025 Earnings Presentation
|
9 May 2025 8:25AM |
$2.990 |
$1.015 |
fallen by
66.05%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Q1 2025 earnings presentation delivered on May 9, 2024
- Continued expansion of RECELL device in U.S. burn and soft tissue repair markets
- Transitioned to a direct sales model in Canada to drive commercial performance
- Achieved key regulatory milestones, including FDA approvals and product label expansions
- Advanced multiple pipeline projects, such as RECELL GO and new indications
- Strengthened operational efficiency and reduced operating expenses year-over-year
- Reported increased quarterly revenues and improved gross margin
- Maintained strong cash position to support business initiatives
- Reiterated fiscal year 2025 financial guidance and growth expectations
- Strategic focus on market expansion, innovation, and operational excellence
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$155 |
AVITA Medical Reports Q1 2025 Financial Results
|
9 May 2025 8:25AM |
$2.990 |
$1.015 |
fallen by
66.05%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- AVITA Medical, Inc. reported its Q1 2025 financial results, showing continued revenue growth.
- The company’s RECELL product line drove increased adoption in wound care and burn treatment segments.
- Operational highlights included commercial expansion and new product development initiatives.
- AVITA Medical provided updates on regulatory approvals and ongoing clinical trials.
- The company continues to focus on strategic market expansion and strengthening its financial position.
- Management emphasized commitment to innovation and long-term growth opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sims Limited (SGM) ORDINARY FULLY PAID |
Materials |
$3,455 |
Application for quotation of securities - SGM
|
9 May 2025 8:25AM |
$15.270 |
$17.880 |
risen by
17.09%
|
|
| Genmin Limited (GEN) ORDINARY FULLY PAID |
Materials |
$10 |
Non-executive Chair provides A$2.0 million in funding
|
9 May 2025 8:25AM |
$0.027 |
$0.010 |
fallen by
62.96%
|
|
GEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Genmin Limited received A$2.0 million funding from Non-executive Chair Mr. Kerry Stokes AC.
- The funding is structured as an unsecured loan with a 12-month maturity period.
- Interest on the loan is set at 8% per annum, payable quarterly in arrears.
- The funds will be used to support Genmin's working capital and ongoing operations.
- The transaction was on arm's length terms and not considered a related party transaction under ASX rules.
- The funding demonstrates continued board support as Genmin advances its African iron ore projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Winchester Energy Limited (WEL) ORDINARY FULLY PAID |
Energy |
$3 |
Winchester successfully defends legal proceedings
|
9 May 2025 8:25AM |
$0.001 |
$0.002 |
risen by
100%
|
|
WEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Winchester Energy Limited has successfully defended legal proceedings.
- The court ruled in favor of Winchester, dismissing all claims.
- No adverse findings or damages were imposed on the company.
- No costs were awarded to the plaintiff.
- The outcome removes legal uncertainty for Winchester Energy Limited.
- The company assures shareholders of its strong legal position.
- Winchester will now focus on ongoing business operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Piedmont Lithium Limited (PLL) ORDINARY FULLY PAID |
Materials |
- |
Earnings Presentation Q1 2025
|
9 May 2025 8:25AM |
$0.100 |
$0.140 |
risen by
40%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$3,554 |
Ceasing to be a substantial holder
|
9 May 2025 8:24AM |
$1.745 |
$2.770 |
risen by
58.74%
|
|
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$632 |
Ceasing to be a substantial holder
|
9 May 2025 8:24AM |
$11.270 |
$12.580 |
risen by
11.62%
|
|
| 8Common Ltd (8CO) ORDINARY FULLY PAID |
Information Technology |
$6 |
Change of Director's Interest Notice - N Lim
|
9 May 2025 8:24AM |
$0.015 |
$0.027 |
risen by
80%
|
|
| Doctor Care Anywhere Group PLC (DOC) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$44 |
Change of Director's Interest Notice - John Stier
|
9 May 2025 8:24AM |
$0.084 |
$0.120 |
risen by
42.86%
|
|
| Mineral Resources Limited (MIN) ORDINARY FULLY PAID |
Materials |
$9,994 |
Ceasing to be a substantial holder
|
9 May 2025 8:24AM |
$20.740 |
$50.570 |
risen by
143.83%
|
|
| Tempest Minerals Limited (TEM) ORDINARY FULLY PAID |
Materials |
$8 |
Change to Managing Director Remuneration Arrangements
|
9 May 2025 8:24AM |
$0.004 |
$0.007 |
risen by
75%
|
|
| Athena Resources Limited (AHN) ORDINARY FULLY PAID |
Materials |
$14 |
Completion of RC Drilling at Byro South
|
9 May 2025 8:24AM |
$0.004 |
$0.006 |
risen by
50%
|
|
| European Lithium Limited (EUR) ORDINARY FULLY PAID |
Materials |
$258 |
Top 20 Option Holders
|
9 May 2025 8:23AM |
$0.053 |
$0.150 |
risen by
183.02%
|
|
| REA Group Ltd (REA) ORDINARY FULLY PAID |
Communication Services |
$24,547 |
REA Group Q3 FY25 financial information released
|
9 May 2025 8:22AM |
$250.080 |
$185.800 |
fallen by
25.70%
|
|
REA - Price-sensitive ASX Announcement
Full Release
Key Points
- REA Group reported revenue and EBITDA growth for Q3 FY25.
- Australian residential business benefited from increased listing volumes and higher depth penetration.
- Commercial and developer segments also contributed positively to overall revenue.
- International businesses, including India and Southeast Asia, showed ongoing momentum and growth.
- Ongoing investments in technology and data capabilities to drive innovation.
- Disciplined cost management supported margin expansion.
- Strategic initiatives include expanding product offerings and strengthening data assets.
- Continued focus on customer experience improvements.
- Positive outlook expressed for the remainder of FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| European Lithium Limited (EUR) ORDINARY FULLY PAID |
Materials |
$258 |
Distribution Schedule
|
9 May 2025 8:22AM |
$0.053 |
$0.150 |
risen by
183.02%
|
|
| European Lithium Limited (EUR) ORDINARY FULLY PAID |
Materials |
$258 |
Application for quotation of securities - EUR
|
9 May 2025 8:22AM |
$0.053 |
$0.150 |
risen by
183.02%
|
|
| Civmec Limited (CVL) ORDINARY FULLY PAID |
Industrials |
$701 |
Investor Presentation - Q3 FY25
|
9 May 2025 8:20AM |
$0.905 |
$1.375 |
risen by
51.93%
|
|
CVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Q3 FY25 saw continued revenue growth and increased margins for Civmec Limited.
- Order book remains robust with significant new contract awards and extensions in resources, energy, and infrastructure.
- Operational highlights include successful project delivery, expansion of fabrication and construction capacity, and strong safety performance.
- The company maintains a diversified project pipeline, reducing reliance on the resources sector alone.
- Sustainability initiatives advanced, with a focus on environmental responsibility and community engagement.
- Financial position remains strong, supporting ongoing investment in capacity and capability.
- Civmec remains committed to operational excellence, safety, and delivering value to shareholders.
- The outlook is positive, supported by a healthy pipeline and favourable market conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Civmec Limited (CVL) ORDINARY FULLY PAID |
Industrials |
$701 |
Civmec Business Update - Q3 FY25
|
9 May 2025 8:20AM |
$0.905 |
$1.375 |
risen by
51.93%
|
|
CVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Civmec reported strong revenue and profitability growth for Q3 FY25.
- The company maintained a robust order book and secured new contracts across multiple sectors.
- Ongoing project execution contributed to improved operational performance.
- Safety, workforce development, and training remain key priorities.
- Civmec continued to invest in facilities and equipment to support business expansion.
- Operational efficiency and client relationship management were emphasized.
- The company’s financial position remains strong, with a positive future outlook.
- Civmec is actively pursuing new opportunities in the resources, energy, infrastructure, and defence sectors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Air New Zealand Limited (AIZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$1,617 |
Notice of share buyback
|
9 May 2025 8:20AM |
$0.560 |
$0.500 |
fallen by
10.71%
|
|
| Gumtree Australia Markets Limited (GUM) ORDINARY FULLY PAID |
Communication Services |
$42 |
Signs MOU with NZME to explore New Zealand Classifieds
|
9 May 2025 8:18AM |
$0.097 |
$0.130 |
risen by
34.02%
|
|
GUM - Price-sensitive ASX Announcement
Full Release
Key Points
- Gumtree Australia Markets Limited (GUM) signs a non-binding MOU with NZME Limited.
- The MOU explores launching a digital general classifieds marketplace in New Zealand.
- GUM brings expertise in online classifieds; NZME has a strong New Zealand media presence.
- The partnership aims to leverage both companies' strengths for a new classifieds offering.
- An exclusive negotiation period is established by the MOU.
- The collaboration would complement NZME's current digital classifieds platforms.
- The MOU is subject to due diligence and final agreements.
- No binding commitment has been made at this stage; the MOU is exploratory.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Macquarie Group Limited (MQG) ORDINARY FULLY PAID |
Financials |
$76,475 |
Macquarie Group Appendix 4G
|
9 May 2025 8:15AM |
$195.890 |
$200.650 |
risen by
2.43%
|
|
| Macquarie Group Limited (MQG) ORDINARY FULLY PAID |
Financials |
$76,475 |
Macquarie Group FY25 Management Discussion and Analysis
|
9 May 2025 8:14AM |
$195.890 |
$200.650 |
risen by
2.43%
|
|
MQG - Price-sensitive ASX Announcement
Full Release
Key Points
- Macquarie Group delivered strong financial performance for FY25, with growth across multiple business segments.
- Asset Management saw increased assets under management and diversified revenue streams.
- Commodities and Global Markets contributed significantly to earnings, driven by client demand and market volatility.
- Banking and Financial Services maintained stable performance, focusing on lending growth and customer retention.
- The Group emphasises robust risk management and regulatory compliance as core operational principles.
- Capital management remains a priority, with prudent capital allocation and continued investment in core businesses.
- Macquarie continues to invest in technology, digital solutions, and talent development to drive future growth.
- Sustainability and ESG initiatives are integrated into business strategies to align with stakeholder expectations.
- The company monitors macroeconomic and market risks closely to adapt strategies and ensure resilience.
- Management is focused on delivering long-term shareholder value through disciplined execution and innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Macquarie Group Limited (MQG) ORDINARY FULLY PAID |
Financials |
$76,475 |
Macquarie Group FY25 Presentation
|
9 May 2025 8:13AM |
$195.890 |
$200.650 |
risen by
2.43%
|
|
MQG - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax for FY24 was $3,522 million, down 32% year-on-year.
- Operating income decreased by 12% to $16.9 billion.
- The board declared a final dividend of $2.55 per share, 40% franked.
- Lower result in Macquarie Asset Management and Commodities & Global Markets segments due to tough market conditions.
- Banking and Financial Services achieved record performance, supported by strong loan, deposit, and funds under management growth.
- Significant investments in green energy, infrastructure, and digital transformation.
- Strong capital and liquidity position maintained, with CET1 ratio of 13.5%.
- Diverse business model and global footprint provide risk mitigation and growth opportunities.
- FY25 outlook is cautious, with focus on disciplined capital management, cost control, and selective investment.
- Ongoing commitment to sustainability and responsible investment, with progress towards net zero targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
